Discover how cancer cells survive in low-glucose environments and evade chemotherapy-induced death. New study sheds light on ...

In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...

Study demonstrates how metabolic imaging differentiates high and low oxidative phosphorylation (OXPHOS) subtypes of ...

A Phase 3 trial of uproleselan failed to improve overall survival in relapsed/refractory AML, though it may benefit primary ...

A phase 3 trial of uproleselan in relapsed/refractory acute myeloid leukemia failed to meet the primary overall survival end ...

Researchers have discovered how chemotherapy can change tumors, making them more vulnerable to new types of treatments. These ...

A novel combination resulted in tumor regression during preclinical lab testing by scientists at the nonprofit Wistar ...

With more than 150 treatments being studied in clinical trials, what is on the horizon for antibody-drug conjugates in breast ...

Researchers from the RMIT University in Australia and Indian institutions unveiled a gold-based cancer drug with promising ...